BlackRock
ERNA icon

BlackRock’s Eterna Therapeutics ERNA Stock Holding History

BlackRock’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$219 Hold
33
– – ﹤0.01% 5594
2026
Q1 		$163 Hold
33
– – ﹤0.01% 5596
2025
Q4 		$984 Hold
33
– – ﹤0.01% 5426
2025
Q3 		$898 Hold
33
– – ﹤0.01% 5354
2025
Q2 		$1.51K Hold
33
– – ﹤0.01% 5337
2025
Q1 		$2.19K Sell
33
-7
-18% -$863 ﹤0.01% 5296
2024
Q4 		$4.39K Hold
40
– – ﹤0.01% 5231
2024
Q3 		$15.7K Hold
40
– – ﹤0.01% 4960
2024
Q2 		$27.4K Sell
40
-2
-5% -$1.5K ﹤0.01% 4961
2024
Q1 		$37.5K Hold
42
– – ﹤0.01% 4932
2023
Q4 		$28K Sell
42
-2
-5% -$1.15K ﹤0.01% 5043
2023
Q3 		$36.1K Sell
44
-3
-6% -$2.76K ﹤0.01% 5062
2023
Q2 		$40.2K Sell
47
-15
-24% -$15.1K ﹤0.01% 5101
2023
Q1 		$79.4K Hold
62
– – ﹤0.01% 5015
2022
Q4 		$74.5K Sell
62
-26
-30% -$36.6K ﹤0.01% 5127
2022
Q3 		$162K Sell
88
-73
-45% -$252K ﹤0.01% 5034
2022
Q2 		$626K Sell
161
-157
-49% -$1.13M ﹤0.01% 4698
2022
Q1 		$4.89M Buy
318
+32
+11% +$607K ﹤0.01% 3976
2021
Q4 		$8.96M Buy
286
+48
+20% +$2.61M ﹤0.01% 3742
2021
Q3 		$16.6M Buy
238
+51
+27% +$4.4M ﹤0.01% 3406
2021
Q2 		$25.3M Buy
+187
New +$26.9M ﹤0.01% 3154
2021
Q1 		– Hold
0
– – – 5120
2020
Q4 		– Hold
0
– – – 4881
2020
Q3 		– Hold
0
– – – 4837
2020
Q2 		– Hold
0
– – – 4811
2020
Q1 		– Hold
0
– – – 4768
2019
Q4 		– Hold
0
– – – 4770
2019
Q3 		– Hold
0
– – – 4717
2019
Q2 		– Hold
0
– – – 4756
2019
Q1 		– Hold
0
– – – 4652
2018
Q4 		– Hold
0
– – – 4718
2018
Q3 		– Hold
0
– – – 4698
2018
Q2 		– Hold
0
– – – 4722
2018
Q1 		– Hold
0
– – – 4565
2017
Q4 		– Hold
0
– – – 4619
2017
Q3 		– Hold
0
– – – 4617
2017
Q2 		– Hold
0
– – – 4653
2017
Q1 		– Hold
0
– – – 4575

Other funds holding ERNA

VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tradewinds Capital Management Bellingham, Washington $563M AUM 41.52% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

BlackRock's ERNA Position: Q2 2026 in Review

BlackRock held its Eterna Therapeutics (ERNA) position steady in Q2 2026 at 33 shares worth $219. The position accounts for ﹤0.01% of the portfolio, ranked #5594.

BlackRock first reported a position in ERNA in Q2 2021 and has held it in 21 quarters since. The position peaked at $25.3M in Q2 2021. 8 funds tracked by Wall St. Rank hold ERNA as of Q2 2026.

  • BlackRock held 33 shares of Eterna Therapeutics worth $219 as of Q2 2026.
  • BlackRock left its Eterna Therapeutics share count unchanged in Q2 2026.
  • Eterna Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5594 holding.
  • BlackRock first reported a position in Eterna Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • BlackRock's Eterna Therapeutics position peaked at $25.3M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.